Assessment of human antihuman antibodies to eculizumab after long-term treatment in patients with paroxysmal nocturnal hemoglobinuria-Reference-Cited by-同舟云学术

Assessment of human antihuman antibodies to eculizumab after long-term treatment in patients with paroxysmal nocturnal hemoglobinuria

Published:2016-02-22 Issue:3 Volume:91 Page:E16-E17
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Hillmen Peter¹,Muus Petra²,Szer Jeffrey³,Hill Anita⁴,Höchsmann Britta⁵,Kulasekararaj Austin⁶,Risitano Antonio M.⁷,Van Den Neste Eric⁸,Liljeholm Maria⁹,Ebrahim Kurt S.¹⁰,Bedrosian Camille L.¹¹,Gao Xiang¹¹,Ames Donna¹¹,Socié Gérard¹²

Affiliation:

1. Section of Experimental Haematology, St James's University Hospital; Leeds United Kingdom

2. Department of Hematology; Radboud University Medical Centre; Nijmegen The Netherlands

3. Department of Clinical Haematology and BMT Service; The Royal Melbourne Hospital; Melbourne Australia

4. Department of Haematology; St James' Institute of Oncology, Leeds Teaching Hospitals; Leeds United Kingdom

5. Institute of Transfusion Medicine, University of Ulm, Institute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen, and University Hospital Ulm; Ulm Germany

6. King's College Hospital; Hill, Denmark, London United Kingdom

7. Dipartimento Di Medicina Clinica E Chirurgia Dell’ Università Degli Studi Di Napoli Federico II; Napoli Italy

8. Hematology Department; Cliniques Universitaires UCL Saint-Luc; Brussels Belgium

9. Hematology Department; University Hospital of Umea; Umea Sweden

10. New England Cancer Specialists; Scarborough Maine

11. Alexion Pharmaceuticals, Inc; Cheshire Connecticut

12. AP-HP Hematology Hospital Saint Louis; Paris France

Publisher

Wiley

Subject

Hematology

Reference10 articles.